Pharma Journalist -

CompleWare and YPrime  partner to offer enhanced service offerings involving Clinical Trials, electronic clinical outcome assessment (eCOA) technology and interactive response…
Read More...

In a bid to ensure transparency and clarity in their drug approval decisions,  U.S FDA Commissioner Scott Gottlieb endeavors to undertake new drug innovation and Scientific progress by…
Read More...

Ophthalmic Pharmaceutical Company, Aerie Pharmaceuticals that seeks to treat patients with open-angle glaucoma and other diseases of the eye declared the appointment of Nils Hauptmann…
Read More...

Ophthotech Corporation enrolled first patient in the Phase 2b randomized, double-masked, sham-controlled clinical trial assessing the efficacy and safety of Zimura complement C5…
Read More...

Developer of surgical implants for treating distal extremity pathology, Centric Medical asserted that the U.S FDA has granted 510 (k) clearance to the Cannulated Screw Internal Fixation…
Read More...

Genetic screening and counseling services company, Counsyl sought approval from the New York State Department of Health to provide Prelude Prenatal Screen in New York therefore…
Read More...

Vantage Cancer Care Network into providing integrated cancer Care ventured into an agreement with Alliance Cancer Specialists, PC ensuring extensive delivery of top-notch Oncology Care…
Read More...

Sarah Cannon Research Institute and South Texas Research Accelerated Therapeutics moved to collaborate ensuring augmenting their globally acclaimed phase I drug development programs…
Read More...

Ipsen and Exelixis declared results of Phase 3 CELESTIAL trial in  patients formerly treated with advanced heptacellular carcinoma. In CELESTIAL, cabozantinib provided a statistically…
Read More...

Antibody discovery and optimization service provider, AvantGen claimed completion of its first cancer therapeutic antibody program in collaboration with Tanabe Research Laboratories USA…
Read More...